T

Thynk Capital

3 employees

Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.

Investor insights

Sectors invested in

Health Care13
Biotechnology13
Pharmaceutical5
Medical5
Therapeutics4
Biopharma2
Emergency Laceration Closures1
Rare disease and primary immunodeficiencies1
Clinical Trials1
Life Science1
Vaccines1
Financial Services1
Construction1
Research and Development1
Bioengineering1
Biomanufacturing1
Biologic Devices1
Surgery1
microMend1
Patient Care1

Funding rounds participated in

$2.9M sweet spot round size

Most of their 16 investments are in rounds between $2.2M and $2.9M

Basic info

Industry

investment management

Sectors

Biotechnology
Health Care

Date founded

2016

Investments made

I

Intelligent Medicine Exchange (IMX) raised undisclosed on August 20, 2021

Investors: Thynk Capital

I

IVIVA Medical Inc raised undisclosed on March 5, 2021

Investors: Bioverge and Thynk Capital

V

Viscient Bio Inc raised undisclosed on May 30, 2019

Investors: Thynk Capital

R

Repair Biotechnologies raised $2.2M on May 7, 2019

Investors: SENS Research Foundation and Thynk Capital

X

X-Vax Technology, Inc. raised undisclosed on April 5, 2019

Investors: Thynk Capital

R

Repair Biotechnologies raised undisclosed on April 1, 2019

Investors: Thynk Capital

E

Elicio Therapeutics raised undisclosed on November 6, 2018

Investors: Thynk Capital

K

KitoTech Medical, Inc. | microMend® raised undisclosed on June 25, 2018

Investors: Thynk Capital

M

Marina Biotech, Inc. raised undisclosed on March 22, 2018

Investors: Thynk Capital

E

Elevian, Inc. raised $2.9M on February 20, 2018

Investors: BOLD Capital Partners and Thynk Capital

FAQ